Finally, Nuveen LLC purchased a new position in Royalty Pharma during the first quarter valued at approximately $27,749,000. Royalty Pharma Trading Up 0.5%Royalty Pharma stock opened at $36.49 on Friday. Royalty Pharma PLC has a 1 year low of $24.05 and a 1 year high of $38.00. On average, equities analysts predict that Royalty Pharma PLC will post 4.49 earnings per share for the current fiscal year. Read MoreReceive News & Ratings for Royalty Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Royalty Pharma and related companies with MarketBeat.com's FREE daily email newsletter.